79
Participants
Start Date
May 31, 2010
Primary Completion Date
August 31, 2010
Study Completion Date
August 31, 2010
Aclidinium bromide 100 μg bid
Aclidinium bromide 100 μg twice-daily via inhalation by Eklira Genuair® inhaler: 1 puff in the morning and evening for 7 days
Aclidinium bromide 200 μg bid
Aclidinium bromide 200 μg twice-daily via inhalation by Eklira Genuair® inhaler: 1 puff in the morning and evening for 7 days
Aclidininum bromide 400 μg bid
Aclidinium bromide 400 μg twice-daily via inhalation by Eklira Genuair® inhaler: 1 puff in the morning and evening for 7 days
Placebo
Placebo via inhalation in the morning and evening for 7 days
Formoterol 12 μg bid
Formoterol 12 μg twice-daily via inhalation by Aerolizer® dry powder inhaler: 1 puff in the morning and evening for 7 days
Almirall Investigational Sites#3, Berlin
Almirall Investigational Sites#4, Berlin
Almirall Investigational Sites#9, Berlin
Almirall Investigational Sites#6, Schwerin
Almirall Investigational Sites#5, Hamburg
Almirall Investigational Sites#1, Groβhansdorf
Almirall Investigational Sites#7, Hanover
Almirall Investigational Sites#2, Hanover
Almirall Investigational Sites#8, Frankfurt
Almirall Investigational Sites#10, Wiesbaden
Almirall Investigational Sites#1, Ghent
Lead Sponsor
AstraZeneca
INDUSTRY